Cecelia R Miller

7PUBLICATIONS

49CO-AUTHORS

Haematological tumoursGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 25, 2026

Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.

|Dec 19, 2025

Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN-Associated and Sporadic NF2-Deficient Meningiomas.

Long-Sheng Chang, Janet L Oblinger, Lai Man Natalie Wu

|Sep 19, 2025

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Jul 02, 2025

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Cecelia R Miller, Ying Huang, John N Allan

|Feb 20, 2024

Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia.

Matthew R Avenarius, Ying Huang, Adam S Kittai

|Oct 18, 2023

Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.

Samantha M Teierle, Ying Huang, Adam S Kittai

Pageof 2

Frequent Collaborators

Jennifer A Woyach

Andrea Visentin

Enrico Gaffo

Moritz Fürstenau

Baliakas Panagiotis

Claudia Haferlach

Karla Plevova

David Oscier

Zadie Davis

Gian Matteo Rigolin

Frequent Collaborators

Jennifer A Woyach

Andrea Visentin

Enrico Gaffo

Moritz Fürstenau